Citizens upgrades Quince Therapeutics to Market Outperform, $77 target
Citizens upgraded Quince Therapeutics to Market Outperform and set a $77.00 price target, implying 148.4% upside from the Sep 21 close of $31.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.